This specifically elicits large-scale accumulation of infiltrating CD8+ lymphocytes and NK cells in tumor tissues, leading to a dose independent reduction in tumor growth in C57BL/6 mice bearing B16-F10 tumors (39). This evidence concerns the gene CD8A and neoplasm.